High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Kevin H. Rhodes exercised options at $154.69 per share and immediately liquidated the position in open market trading, reducing his direct equity stake by 15%.
3M stock has more than doubled over the past three years, while current checks suggest the shares trade below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and also screen as undervalued on traditional earnings multiples. At the same time, a mixed broader valuation score and fresh legal action over PFAS chemicals mean the gap between price and estimated value is not a straightforward story. 3M has delivered a 103.6% return over the last three years, which puts...
If you are wondering whether 3M stock is offering fair value right now, you are not alone. A closer look at its current pricing can help frame your next move. 3M last closed at US$165.91, with returns of 4.2% over 7 days, 8.8% over 30 days, 2.5% year to date and 14.4% over 1 year, as well as 120.9% over 3 years and 19.4% over 5 years. Recent attention around 3M has included ongoing coverage of its business updates and long term restructuring efforts. Many investors watch these closely for...
The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.
3M Company has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
As Honeywell International has outperformed the Nasdaq Composite over the past year, analysts remain moderately optimistic about the stock’s prospects.
In late May 2026, the Australian government filed a lawsuit against 3M seeking A$1.40 billion in compensation over PFAS “forever chemicals” used in firefighting foam at defense bases. This case adds a new international dimension to 3M’s existing PFAS exposure, raising fresh questions about the scale and duration of its environmental liabilities. We’ll now examine how this new Australian PFAS lawsuit, and its potential financial and reputational impact, could affect 3M’s investment...
If you are wondering whether 3M at around US$146.52 is a bargain, fully priced, or somewhere in between, it helps to break the story into clear valuation checks rather than just scanning the share price chart. The stock has returned 1.2% over the last 7 days and 0.9% over the last 30 days, with a year to date return of 9.5% decline and a 1 year return of 8.2%. This points to a mix of shorter term softness and longer term recovery, alongside a very large 3 year return and a modest 5 year...
3M Company (NYSE:MMM) is included among the 10 Innovative Dividend Stocks to Buy Right Now. On April 22, RBC Capital Markets analyst Deane Dray lowered the firm’s price target on 3M Company (NYSE:MMM) to $133 from $134 and kept an Underperform rating on the shares. The analyst said the company delivered a modest and low-quality […]
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.